Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000584496 | SCV000687315 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002060576 | SCV002454788 | likely benign | Ataxia-telangiectasia syndrome | 2022-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000584496 | SCV004849041 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-11-14 | criteria provided, single submitter | clinical testing | The c.1607+20T>C intronic alteration consists of a T to C substitution 0 nucleotides after coding exon 9 in the ATM gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |